These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 8041201

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Plasma viremia in human immunodeficiency virus infection.
    Coombs RW, Collier AC, Allain JP, Nikora B, Leuther M, Gjerset GF, Corey L.
    N Engl J Med; 1989 Dec 14; 321(24):1626-31. PubMed ID: 2511447
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevalence of viremia in human immunodeficiency virus-infected patients with renal disease.
    Kimmel PL, VedBrat SS, Pierce PF, Umana WO, Shepherd L, Verme DA, Hirsch RP, Hellman KB.
    Arch Intern Med; 1989 Dec 14; 155(15):1578-84. PubMed ID: 7618979
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.
    Clark SJ, Saag MS, Decker WD, Campbell-Hill S, Roberson JL, Veldkamp PJ, Kappes JC, Hahn BH, Shaw GM.
    N Engl J Med; 1991 Apr 04; 324(14):954-60. PubMed ID: 1900576
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CD4+:neopterin ratio correlates with p24 antigenaemia in HIV infected patients.
    Crocchiolo PR, Lizioli A, Cantaluppi P, Filippi C, D'Agostino F, Cambié G, Panzeri MP, Nardella ML.
    J Clin Lab Immunol; 1990 Feb 04; 31(2):55-7. PubMed ID: 1983767
    [Abstract] [Full Text] [Related]

  • 11. [Survival and disease progression in 251 patients with HIV-1 infection. Study of p24 antigen and viral burden as prognosis makers. Their value at 4 years of follow-up].
    Rubio Caballero M, Rubio Rivas C, Nogués Biau A, Falguera Sacrest M, Manonelles Fernández A.
    An Med Interna; 2001 Oct 04; 18(10):517-20. PubMed ID: 11766280
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The quantification of human immunodeficiency virus viremia in patients with rapid and slow progression of the disease].
    Bravo R, Soriano V, Martín R, del Romero J, Dronda F, Gutiérrez M, Martínez P, Valencia E, Moreno V, Laguna F.
    Med Clin (Barc); 1995 Apr 15; 104(14):530-4. PubMed ID: 7776732
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement.
    Ledergerber B, Flepp M, Böni J, Tomasik Z, Cone RW, Lüthy R, Schüpbach J.
    J Infect Dis; 2000 Apr 15; 181(4):1280-8. PubMed ID: 10751136
    [Abstract] [Full Text] [Related]

  • 16. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia.
    Royal W, Selnes OA, Concha M, Nance-Sproson TE, McArthur JC.
    Ann Neurol; 1994 Jul 15; 36(1):32-9. PubMed ID: 7912918
    [Abstract] [Full Text] [Related]

  • 17. Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma.
    Furrer H, Barloggio A, Egger M, Garweg JG, Swiss HIV Cohort Study.
    Ophthalmology; 2003 Feb 15; 110(2):432-6. PubMed ID: 12578793
    [Abstract] [Full Text] [Related]

  • 18. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J.
    AIDS Rev; 2002 Feb 15; 4(2):83-92. PubMed ID: 12152521
    [Abstract] [Full Text] [Related]

  • 19. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
    Cartón JA, Maradona JA, de Oña M, Asensi V, Melón S, García-Alcalde ML, Rodríguez-Junquera M, Moreno-Torrico A, de Zárraga M.
    Med Clin (Barc); 1999 Sep 04; 113(6):205-9. PubMed ID: 10472608
    [Abstract] [Full Text] [Related]

  • 20. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
    El Amari EB, Toutous-Trellu L, Gayet-Ageron A, Baumann M, Cathomas G, Steffen I, Erb P, Mueller NJ, Furrer H, Cavassini M, Vernazza P, Hirsch HH, Bernasconi E, Hirschel B, Swiss HIV Cohort Study.
    AIDS; 2008 May 31; 22(9):1019-28. PubMed ID: 18520345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.